BE指导原则

BE指导原则 (BE Guiding Principles) is a specialized online resource developed by the National Institutes for Food and Drug Control (NIFDC) in China. It aggregates bioequivalence (BE) guidelines and related regulatory documents from major agencies such as the U.S. FDA and the EuRoPEan Medicines Agency (EMA). This tool is designed to assist researchers, regulatory Professionals, and phArmaceutical scientists in quickly locating authoritative guidance on bioequivalence studies, which are essential for drug APProval and generic drug development.

What it does

The platform provIDEs a searchable Database of bioequivalence guidelines and principles. Users can enter keywords to retrieve relevant documents, summaries, and regulatory requirements. The tool focuses on Chinese and international Standards, helping users navigate the complex landscape of BE study design, data analysis, and submission processes.

Key capabilities

• Multi-agency coveRAGe: Includes guidelines from FDA, EMA, and Chinese regulatory authorities, allowing comparative analysis.
• Keyword search: Enables efficient retrieval of specific topics such as study design, statistical methods, and bioanalytical validation.
• Regular updates: The database is mAIntained by NIFDC, though update frequency may vary.
• free access: No subscription or registration is required to use the search functionality.

Who it is for

This resource is primarily intended for professionals involved in pharmaceutical research and development, including CLInical pharmacologists, regulatory affairs specialists, CRO staff, and academic researchers. It is particularly useful for those preparing bioequivalence studies for generic drug applications or working on regulatory submissions in multiple regions.

How to get started

1. Visit the official NIFDC search page (URL provided in the source data).
2. Enter relevant keywords in Chinese or English, such as “生物等效” or “bioequivalence”.
3. Browse the search results and click on documents to view details.
4. Use the Information for reference; note that some documents may be in Chinese or require translation.

Pricing and access caveat

BE指导原则 is freely accessible via the web, with no paywall or account required. However, users should be aware that the availability and comprehensiveness of documents may vary, and the tool does not provide AI-generated insights or interACTive features beyond search. It serves as a reference portal rather than a Generative AI application. For the most current guidelines, always cross-check with official regulatory websites.